双特异性单克隆抗体在肿瘤治疗中的应用
Recent advances and applications of bispecific monoclonal antibodies in cancer therapy
摘要
双特异性单克隆抗体(BsMAb)是含有两个不同配体结合位点的免疫球蛋白分子,在疾病的诊断治疗上具有较大临床应用潜力,特别在肿瘤治疗方面,有其不容忽视的优越性。现综述近年来BsMAb在肿瘤治疗中的研究及应用进展。同时,对其人源化进程也进行了概述。
出处
《国外医学（肿瘤学分册）》
2005年第4期270-273,共4页
Foreign Medical Sciences (Cancer Section)
参考文献23
-
1Withoff S, Helfrich W. Bi-specific antibody therapy for the treatment of cancer. Curr Opin Mol Ther,2001,3( 1 ) :53-62.
-
2Talac R, Nelson H. Current perpectives of bispecific antibody-based immunotherapy. J Biol Regul Homeost Agents, 2000, 14 ( 3 ): 175-181.
-
3Cao Y, Lam L. Bispecific antibody conjugates in therapeutics. Adv Drug Deliv Rev,2003,55(2) :171-197.
-
4Annemiek B, Hwidi H, Jan GJ. Immunotherapeutic perspective for bispecific antibodies. Immunology Today,2000,21 (8) :391-397.
-
5Chambers CA, Allison JP. Costimulatory regulation of T-cell function. Curr Opin Cell Biol, 1999,11 (2) :203-210.
-
6Keler T, Wallace PK, Vitale LA, et al. Differential effect of cytokine treatment on FcαR Ⅰ and FcγR Ⅰ mediated tumorcytotoxicity by mionocyte. J Immunol,2000,164( 11 ) :5746-5752.
-
7Hartmann F, Renner C, Jung W,et al. Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease:role of infusion schedule and costimulation with cytokines. Clin Cancer Res, 2001,7 ( 7 ): 1873-1881.
-
8Borchmann P, Schnell R, Fuss, et al. Phase Ⅰ trial of the novel bispecific molecule H22 × Ki-4 in patients with refractory Hodgkin lymphoma. Blood,2002,100(9) :3101-3107.
-
9Ford CH,Osborne PA, Rego BG, et al. Bispecific antibody targeting of doxorubicin to carcinoembryonic antigen-expressing colon cancer cell lines in vitro and in vivo. Int J Cancer,2001,92(6) :851-855.
-
10Bagshawe KD,Sharma SK, Burke,PJ, et al. Developments with targeted enzymes in cancer therapy. Curr Opin Immunol, 1999,11 ( 5 ):579-583.
-
1杨淑华,牛瑞芳.双特异性单克隆抗体在乳腺癌免疫治疗中的研究进展[J].国外医学（肿瘤学分册）,2005,32(6):447-450. 被引量：3
-
2张敏,李佳,俞德超.单克隆抗体药物在肿瘤治疗中的研究进展[J].实用肿瘤杂志,2015,30(6):495-500. 被引量：5
-
3杜军,周晓军.荧光原位杂交技术在实体瘤诊断中的应用[J].医学研究生学报,2009,22(2):213-216. 被引量：8
-
4郭英,邹启云,王丽.美罗华治疗B细胞淋巴瘤7例的观察及护理[J].中国误诊学杂志,2005,5(16):3175-3176. 被引量：7
-
5史晓宇(综述),周建华(审校).贝伐单抗治疗转移性结直肠癌[J].国际肿瘤学杂志,2008,35(3):209-211.
-
6黄炎,程丹,杨继元.胃肠道肿瘤的靶向治疗[J].国际肿瘤学杂志,2017,44(1):71-74.
-
7张红雨,陈红涛,彭培健.弥漫大B细胞淋巴瘤患者Bcl-2、p53和CD55表达与利妥昔单抗疗效的相关性研究[J].中华临床医师杂志（电子版）,2010,4(12):34-37. 被引量：2
-
8谢峥,万有才.贝伐珠单抗联合顺铂和局部放疗治疗晚期子宫颈腺癌的疗效观察[J].实用肿瘤杂志,2016,31(5):455-458. 被引量：2
-
9牛占恩,袁堂玲,李霞,徐胜军.美罗华联合化疗治疗非霍奇金淋巴瘤9例分析[J].中国误诊学杂志,2007,7(24):5923-5923.
-
10陆世丰,陆化.单克隆抗体治疗恶性血液病的研究进展[J].中国误诊学杂志,2008,8(6):1283-1285. 被引量：1
